Pulse Biosciences (PLSE) Total Debt (2021 - 2023)
Pulse Biosciences (PLSE) recorded quarterly Total Debt of $65.0 million in Q1 2023, little changed quarter-over-quarter from $65.0 million in Q4 2022.
Pulse Biosciences (PLSE) Total Debt (2021 - 2023) Analysis & Trends
Pulse Biosciences' Total Debt history runs 3 years deep, the most recent figure standing at $65.0 million for Q1 2023.
- In Q1 2023, Total Debt changed N/A year-over-year to $65.0 million; the TTM figure through Mar 2023 stood at $65.0 million (changed N/A YoY), while the FY2022 annual figure was $65.0 million, changed N/A from the prior year.
- Total Debt was $65.0 million for Q1 2023 at Pulse Biosciences, roughly flat from $65.0 million in the prior quarter.
- In the past five years, Total Debt ranged from a high of $65.0 million in Q3 2022 to a low of $41.0 million in Q1 2021.
- Historically, Total Debt has averaged $59.0 million across 3 years, with a median of $65.0 million in 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | - |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 17.28 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 12.57 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 259.93 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 202.80 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 5.08 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 2.46 Bn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | - |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 9.46 Bn |
| 10 | Pulse Biosciences | 1.68 Bn | 1.68 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 65.00 Mn |
| Dec 31, 2022 | 65.00 Mn |
| Sep 30, 2022 | 65.00 Mn |
| Mar 31, 2021 | 41.00 Mn |